Clinical Trial Update: Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating teriparatide for fracture healing in incomplete atypical femur fractures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non Displaced Atypical Femoral Fractures

Drugs mentioned

• Teriparatide (Teriparatide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Non Displaced Atypical Femoral Fractures | Phase 3 | Status: COMPLETED